H, M., SJ, W., V, R., & FB, N. (2026). Powering Neurology Drug Development Trials to Reduce False Negative Results. Clinical and translational science, 19(9), e70722. https://doi.org/10.1111/cts.70722
Chicago Style (17th ed.) CitationH, Mori, Wiklund SJ, Ramanarayanan V, and Nahab FB. "Powering Neurology Drug Development Trials to Reduce False Negative Results." Clinical and Translational Science 19, no. 9 (2026): e70722. https://doi.org/10.1111/cts.70722.
MLA (9th ed.) CitationH, Mori, et al. "Powering Neurology Drug Development Trials to Reduce False Negative Results." Clinical and Translational Science, vol. 19, no. 9, 2026, p. e70722, https://doi.org/10.1111/cts.70722.
Warning: These citations may not always be 100% accurate.